Search results
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 5 days agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...
Emcure has better listed pharma alternatives
The Economic Times· 5 days agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical market. The...
Emcure Pharmaceuticals' IPO subscription closes today | India Infoline
India Infoline· 2 days agoOn the third day of bidding, at the time of writing on July 5, 2024 at 12:12 pm, Emcure Pharmaceuticals IPO is witnessing a overall subscription of 8.83 times.
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 6 days agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.
Emcure Pharmaceuticals Raises Rs 582.6 Crore from Institutional Investors | India Infoline
India Infoline· 5 days agoPune-based Emcure Pharmaceuticals raises Rs 582.6 crore from institutional investors through an anchor book.
Emcure Pharma Backed By Bain Capital Mobilises ₹583 Crore From Anchor Investors
Free Press Journal· 5 days agoBain Capital-backed Emcure Pharmaceuticals on Tuesday said it has garnered Rs 583 crore from anchor...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 6 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 5 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Emcure Pharmaceuticals IPO opens today | India Infoline
India Infoline· 4 days agoThe IPO, backed by Bain Capital, has a price band set between ₹960 and ₹1,008 per share and will close on July 5.
Subscribe Emcure Pharmaceuticals Ltd; KR Choksey
CNBC Awaaz· 5 days agoKR Choksey, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.